Hematology

A new analysis of early total therapy clinical trials has revealed that up to one-third of patients with newly diagnosed multiple myeloma may achieve long-term survival.

A new UK clinical trial has found that children undergoing stem cell transplants may safely receive fewer blood transfusions.

New research from COMy 2025 reveals a high rate of infections among people with relapsed or refractory multiple myeloma receiving bispecific antibodies…

New research, from COMy 2025, has found that specific senescence-associated biomarkers are significantly correlated with frailty and overall survival in newly diagnosed multiple myeloma.

At COMy 2025, researchers highlighted barriers to EMA-approved CAR-T cell therapy access due to age, comorbidities, and inequality.

A study presented at COMy 2025 found that dual MRD testing with bone marrow flow cytometry and PET/CT imaging better predicts progression-free survival in patients with multiple myeloma after autologous stem cell transplantation.

Despite therapeutic advances, delayed diagnosis of amyloid light-chain amyloidosis remains a major clinical challenge, according to data shared at the 2025 COMy Congress.